SEC Form 4 Summary VRTX

VRTX officer Charles F. Wagner Jr. reports $8.37 million share sale

Vertex Pharmaceuticals officer Charles F. Wagner Jr. sold 15,286 VRTX shares for $8,374,740.82 in one transaction.

Transaction Value:
$8,374,740.82
Shares transacted:
15,286
Average price:
$547.87
Insider:

The Form 4 filing, an SEC report of insider share activity, lists November 12, 2026, as the transaction date. It was filed on November 16, four days later. The reported seller, Charles F. Wagner Jr., is an officer of Vertex Pharmaceuticals (VRTX).

Transaction details

Transaction
Date of Earliest Transaction2026-11-12
Date of Latest Transaction2026-11-12
Buy/Sellsell
Transaction Count1
Shares Transacted15,286
Price$547.87
Total Transaction Value$8,374,740.82
Insider
Ticker SymbolVRTX
CompanyVERTEX PHARMACEUTICALS INC / MA
Insider NameWAGNER CHARLES F JR
Insider TitleEVP, CO & FO
Sector - IndustryHealthcare - Biotechnology
Holdings
Total Shares Owned After Transaction31,764
Position Size Change32.49%
Filing
Filing Date2026-11-16
SEC LinkView filing

FAQ

What type of transaction is this?

This was a share sale reported under transaction code S. It involved one transaction in Vertex Pharmaceuticals stock. The available details do not identify where the shares were sold.

What was the average price of the transaction?

The reported average price was $547.87 per share for the 15,286 shares sold on November 12, 2026.

How did this transaction affect the insider's holdings?

He sold 15,286 shares and reported 31,764 shares owned after the sale. The shares sold made up 32.49% of his reported shares before the trade.

What's the total transaction value?

The total transaction value was $8,374,740.82 for the one reported sale.

Are there any special circumstances around this transaction?

The transaction information includes a Rule 10b5-1 trading-plan reference, but its scope is unclear. These plans set trading instructions in advance. No footnote text or plan terms were available for this report. The reference alone does not confirm whether a plan covered this specific sale. The plan's start date and trading schedule are unknown.

Source: SEC Form 4 filing.

For research purposes only; not investment advice.

Follow the Newswire
Feedly RSS feed
About RSS

Get new articles in your feed reader as they are published. Add our RSS feed to Feedly or another RSS reader.

Instant SEC Form 4 alerts

Get the next insider trade alert in real time.

Follow the filings behind the headlines. Get matching insider trade alerts sent straight to your email or Telegram, with links to the original SEC filings. Choose Premium for instant alert delivery and ticker-level filters.

Try instant alerts free 10 trading days · No credit card required

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
  • 20 years of alert history
  • Live alert directory updates
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and SEC filing links
  • Access to the alert directory hourly refreshes
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.